Clinical trial · Observational
The ONCOCAMP Study
A Retrospective-prospective, Observational, Multicentric Study to Record Data From the ROC Platform and Monitor the ROC Performance
NCT06270602CI-TRIAL-00099467recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The present study is a retrospective-prospective observational and multicentric study aiming to collect data relating to all patients included in the ROC platform. All ROC centers will be involved in the present study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Data collection (prospective) | Other | — | UNRESOLVED |
| Data collection (retrospective) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Cohort A (Retrospective):
- description
- All consecutive patients entered in the ROC platform from the start of platform activation (November 2018) until the date in which the study is approved by the local ethical committee (Investigator is allowed to enroll patients) will be enrolled. The retrospective cohort will be made by more than 40000 patients already included in the platform and entered a GOM path
- interventionNames
- Other: Data collection (retrospective)
- label
- Cohort B (Prospective):
- description
- All consecutive patients who enter in the ROC platform as for clinical practice from the date in which the study is approved by the local ethical committee (Investigator is allowed to enroll patients).
- interventionNames
- Other: Data collection (prospective)
Primary outcomes (13)
- measure
- Incidence for each tumor of the patients included in the ROC platform
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * signed informed consent * registration in the ROC platform
References
Publications (2)
- DERIVEDPorciello G, Crispo A, Di Carlo FPM, Rocco P, Luongo A, Russo N, Palumbo E, Vitale S, Coluccia S, Prete M, Di Lauro T, Abbadessa L, Di Martino A, Mozzillo AL, Racca E, Piccirillo A, Di Giacomo V, D'Amico M, Fontana M, Augustin LSA, D'Errico D, Coppola E, Stallone T, Maiolino P, Parascandolo I, Turra V, Pignata S; NUTRISCREEN Collaborative Research Group. Physical Activity, Nutritional Status, and Health-Related Quality of Life in Newly Diagnosed Cancer Patients: Evidence from the NUTRISCREEN Project. Nutrients. 2026 Mar 5;18(5):844. doi: 10.3390/nu18050844. PMID 41830013
- DERIVEDPorciello G, Di Lauro T, Luongo A, Coluccia S, Prete M, Abbadessa L, Coppola E, Di Martino A, Mozzillo AL, Racca E, Piccirillo A, Di Giacomo V, Fontana M, D'Amico M, Palumbo E, Vitale S, D'Errico D, Turra V, Parascandolo I, Stallone T, Augustin LSA, Crispo A, Celentano E, Pignata S. Optimizing Nutritional Care with Machine Learning: Identifying Sarcopenia Risk Through Body Composition Parameters in Cancer Patients-Insights from the NUTritional and Sarcopenia RIsk SCREENing Project (NUTRISCREEN). Nutrients. 2025 Apr 18;17(8):1376. doi: 10.3390/nu17081376. PMID 40284239